IntoCell, Inc. (KOSDAQ:287840)
24,400
+900 (3.83%)
At close: Aug 4, 2025, 3:30 PM KST
IntoCell Revenue
IntoCell had revenue of 109.17M KRW in the quarter ending March 31, 2025, with 63.75% growth. This brings the company's revenue in the last twelve months to 2.95B, up 176.59% year-over-year. In the year 2024, IntoCell had annual revenue of 2.91B with 79.72% growth.
Revenue (ttm)
2.95B
Revenue Growth
+176.59%
P/S Ratio
122.91
Revenue / Employee
n/a
Employees
n/a
Market Cap
362.28B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.91B | 1.29B | 79.72% |
Dec 31, 2023 | 1.62B | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | 140.03M | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.10T |
SK hynix | 77.21T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hanwha Aerospace | 15.28T |
Hyundai Motor Company | 178.98T |
HD Hyundai Heavy Industries | 15.32T |
Doosan Enerbility | 15.88T |